![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, April 19, 2021 4:30:36 AM
Relief Therapeutics pulled the plug in time. There is no more money and NeuroRx must look for new investors. May be Big Rock Partners Acquisition Corp. is one of them. You can place a bet that the patent will stay with Relief Therapeutics. No way for others to make a lot of money with it!
..... and finally: how long do you think the new investors will be available?
1) the patent is decisive
2) Relief is now researching in Germany and is very successful
3) NeuroRx tries to simulate something under ZYESAMI that is actually RLF-100. Therefore, ZYESAMI is unknown to FDA and there is no EUA also.
4) The loss that GEM is currently recording, will be compensated very quickly after Relief receives approval for the "new" RLF-100.
Now the content of Relief's e-mail, dated April 15, 2021, also has a different meaning:
Once Relief has received and analyzed the full data set from the U.S. phase 2b/3 trial, the Company will decide on the best path forward for the development of RLF-100 in Europe and other territories.
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM